Pall Corp (NYSE:PLL) will unveil its latest earnings on Thursday, December 8, 2011. The average estimate of analysts is for net income of 65 cents per share, a rise of 6.6% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from 71 cents. Between one and three months ago, the average estimate moved down. It also has dropped from 66 cents during the last month. Analysts are projecting profit to rise by 13% versus last year to $3.13.
The company missed estimates last quarter after beating forecasts in the prior two. In the fourth quarter of the last fiscal year, the company reported profit of 76 cents per share versus a mean estimate of net income of 88 cents per share. In the third quarter of the last fiscal year, the company beat estimates by one cent. On average, analysts predict $648 million in revenue this quarter, a rise of 7% from the year ago quarter. Analysts are forecasting total revenue of $2.88 billion for the year, a rise of 5.1% from last year’s revenue of $2.74 billion.
Competitors to Watch: Nordson Corporation (NASDAQ:NDSN), General Electric Company (NYSE:GE), CLARCOR Inc. (NYSE:CLC), 3M Company (NYSE:MMM), Donaldson Company, Inc. (NYSE:DCI), Thermo Fisher Scientific Inc. (NYSE:TMO), Danaher Corporation (NYSE:DHR), Parker-Hannifin Corp. (NYSE:PH), Teleflex Incorporated (NYSE:TFX), and Flow International Corp. (NASDAQ:FLOW).
The Cooper Companies, Inc. (NYSE:COO) will unveil its latest earnings on Thursday, December 8, 2011. The average estimate of analysts is for net income of $1.21 per share, a rise of 16.3% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from $1.22. Between one and three months ago, the average estimate was unchanged. It has since dropped over the last month. For the year, analysts are projecting profit of $4.23 per share, a rise of 39.1% from last year.
Last quarter, the company beat estimates by 7 cents, coming in at net income of $1.15 a share versus the estimate of profit of $1.08 a share. It marked the fourth straight quarter of beating estimates. Analysts are projecting a rise of 13.9% in revenue from the year-earlier quarter to $356.9 million.
Competitors to Watch: STAAR Surgical Company (NASDAQ:STAA), Teleflex Incorporated (NYSE:TFX), Utah Medical Products, Inc. (NASDAQ:UTMD), Atrion Corporation (NASDAQ:ATRI), Covidien plc (NYSE:COV), Shamir Optical Industry Ltd. (NASDAQ:SHMR), Novartis AG (NYSE:NVS), C.R. Bard, Inc. (NYSE:BCR), Johnson & Johnson (NYSE:JNJ), and Boston Scientific Corp. (NYSE:BSX).